Betamethasone Sodium Phosphate And Betamethasone Acetate Injection, Suspension
Product Images NDC 76420-007

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Sodium Phosphate And Betamethasone Acetate (NDC 76420-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Betamethasone Sodium Phosphate And Betamethasone A 1)

Chemical structure diagram of Betamethasone Sodium Phosphate, one of the active ingredients in the Betamethasone Sodium Phosphate and Betamethasone Acetate injection suspension product by Asclemed USA, Inc.*

FDA Label Image

Structural Formula (Betamethasone Sodium Phosphate And Betamethasone A 2)

Chemical structure diagram showing the molecular structure of betamethasone acetate with atomic symbols and bonds clearly depicted.*

FDA Label Image

Label (Betamethasone Sodium Phosphate And Betamethasone A 3)

Label for Betamethasone Sodium Phosphate and Acetate 6 mg/mL injectable suspension, relabeled by Enovachem Pharmaceuticals. The label includes NDC 76420-007-05, quantity of 5, lot and batch number placeholders, and storage instructions. Distributed by American Regent, Inc., this prescription injection is supplied as an injectable suspension.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.